Article
Version 1
Preserved in Portico This version is not peer-reviewed
Effects of S-Adenosylhomocysteine-Hydrolase Down-Regulation on Wnt Signaling Pathway in SW480 Cells
Version 1
: Received: 14 September 2023 / Approved: 14 September 2023 / Online: 15 September 2023 (11:03:03 CEST)
A peer-reviewed article of this Preprint also exists.
Pavičić, I.; Rokić, F.; Vugrek, O. Effects of S-Adenosylhomocysteine Hydrolase Downregulation on Wnt Signaling Pathway in SW480 Cells. Int. J. Mol. Sci. 2023, 24, 16102. Pavičić, I.; Rokić, F.; Vugrek, O. Effects of S-Adenosylhomocysteine Hydrolase Downregulation on Wnt Signaling Pathway in SW480 Cells. Int. J. Mol. Sci. 2023, 24, 16102.
Abstract
Disorder of S-adenosylhomocysteine hydrolase (AHCY) activity leads to the potentially lethal rare disease AHCY deficiency, first described in 2004 by Baric and co-workers [1]. In order to shed new light on molecular aspects of the disease, in particular changes at transcriptome level, we enabled knock-down of AHCY expression in model systems such as the colon cancer cell line SW480 to simulate the environment occurring in AHCY deficiency patients. Further, we per-formed deep sequencing of mRNA, followed by differential expression and molecular pathway analysis. Fifteen differentially expressed networks were identified, and interestingly, we found a predicted effect of AHCY down-regulation on the expression of the Lymphoidphoid enhanc-er-binding factor 1 (LEF1) gene, indicating changes in the TCF4/LEF1 complex. LEF1, a member of the T-cell Factor (TCF)/LEF1 family of high-mobility group transcription factors, is a down-stream mediator of the Wnt/β-catenin signaling pathway [2]. LEF1 is essential in stem cell maintenance, and especially in its role in epithelial-mesenchymal transition (EMT). Western blot analysis of LEF1 protein expression confirmed our transcriptomic data predictions and revealed significantly increased LEF1 protein in AHCY- deficient cells, providing a novel link between AHCY and cancer cell phenotype.
Keywords
AHCY deficiency, S-adenosylhomocysteine (SAH), LEF1, STAT3, MYC, metastasis, EMT, cancer cell phenotype, shRNA, Next-generation sequencing,
Subject
Biology and Life Sciences, Biochemistry and Molecular Biology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment